Innovent Biologics, INC. will hold a shareholder's special meeting on June 21st, 2024, at the administrative building of Innovent Biologics in Suzhou Industrial Park, China. The meeting will review and vote on a series of resolutions, including approval of proposals to grant restricted shares under the 2020 Restricted Share Plan to Dr. Yu Dechao, Mr. Xi Hao, Ms. Xu Yiying, Dr. Charles Leland Cooney, Dr. Chen Kai, Mr. Gary Zieziula, and Mr. Chen Shuyun, as well as approval of the 2024 Share Incentive Plan, which will be implemented after the initial public offering and has a plan authorization limit. Shareholders will appoint representatives to attend the meeting and vote on their behalf by completing the proxy form. All relevant documents must be delivered to Hong Kong Securities Registration Co., Ltd. at least 48 hours prior to the meeting.

Innovent Biologics, INC. will hold a shareholder's special meeting on June 21st, 2024, at the administrative building of Innovent Biologics in Suzhou Industrial Park, China. The meeting will review and vote on a series of resolutions, including approval of proposals to grant restricted shares under the 2020 Restricted Share Plan to Dr. Yu Dechao, Mr. Xi Hao, Ms. Xu Yiying, Dr. Charles Leland Cooney, Dr. Chen Kai, Mr. Gary Zieziula, and Mr. Chen Shuyun, as well as approval of the 2024 Share Incentive Plan, which will be implemented after the initial public offering and has a plan authorization limit. Shareholders will appoint representatives to attend the meeting and vote on their behalf by completing the proxy form. All relevant documents must be delivered to Hong Kong Securities Registration Co., Ltd. at least 48 hours prior to the meeting.